Pituitary tumor patients monitored for clues to recurrence
NCT ID NCT00599092
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 1,250 people with pituitary tumors to learn what predicts tumor return or ongoing disease. Researchers will track survival and other health markers over time. No new treatment is given—the goal is simply to gather information that may improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITUITARY TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center, Pituitary Center
RECRUITINGLos Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple eye-tracking test may replace button-pressing exams for pituitary tumor patients
- Immunotherapy combo shows promise for tough pituitary tumors
- Scientists map immune cells in pituitary tumors to unlock new treatments
- How do patients feel after Nose-Based brain surgery? new study aims to find out
- Nerve block could make brain tumor surgery safer and less painful
- New microscope could help brain surgeons see tumors in real time